Vitronectin regulates osteoclastogenesis and bone remodeling in a mouse model of osteoporosis

Mari Nakashima1, Akiko Suzuki1, Kei Hashimoto2

  • 1Graduate School of Humanities and Sciences, Ochanomizu University, Tokyo, Japan.

PubMed
Summary

Vitronectin (VN) deficiency exacerbates osteoporosis by increasing osteoclast activity and bone loss. Lack of VN in ovariectomized mice led to more osteoclasts and worsened bone structure, highlighting VN's role in bone remodeling.